The in vivo studies were performed with [18F]F-TZ(PSMA)-LEGU-TLR7 to assess the in vivo kinetics, stability, metabolism, biodistribution, and tumor-targeting properties of the T-SMPDCs. The gene discussed is TLR7; the disease is neoplasm.